Summary
Updated Aug 30, 2026
Hayon Igal Louria is Chief Technology Officer of Raphael Pharmaceutical Inc. (RAPH). 1 SEC Form 4 filing on record, dated 6 April 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Hayon Igal Louria has reported, most recent first.
Most Active Insiders Right Now
Hayon Igal Louria has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- DM Trust Aggregator, LLC - $88.83M of BROS open-market activity in the last 90 days
- SUMMIT PARTNERS L P - $88.55M of KVYO open-market activity in the last 90 days
- Ronald Clarke - $88.51M of CPAY open-market activity in the last 90 days
- Yousif Mohammed Ali Nasser Al-Nowais - $88.47M of NESR open-market activity in the last 90 days
- Thomas J. Nimbley - $87.92M of PBF open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $7.98B of SVRE open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Hayon Igal Louria?
Hayon Igal Louria is a corporate insider, tracked as Chief Technology Officer of Raphael Pharmaceutical Inc. (RAPH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Hayon Igal Louria last file a Form 4?
The only primary Form 4 on record is dated 6 April 2026.
Where can I see all of Hayon Igal Louria's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Hayon Igal Louria and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
